Catalog No.
Product Name
Application
Product Information
Citations
-
Drug Impurity
Dexmedetomidine impurity 10 is a chemical impurity associated with the sedative agent Dexmedetomidine. This compound may be utilized in pharmacological studies to evaluate the purity and stability of Dexmedetomidine formulations. Its analysis can provide insights into drug quality, safety, and efficacy, contributing to the overall assessment of therapeutic applications and regulatory compliance. -
Drug Impurity
Abacavir Impurity 1 is a known impurity associated with the antiretroviral drug Abacavir. This compound is utilized primarily in analytical chemistry for quality control and validation studies during the manufacturing of Abacavir. Its detection and quantification are crucial for ensuring the purity and safety of pharmaceutical formulations containing Abacavir. -
Drug Impurity
Donepezil impurity 4, known as Donepezil alkene pyridine N-oxide, is a chemical impurity associated with the synthesis of Donepezil. This compound is important for analytical research and quality control in pharmaceutical development, particularly in assessing the purity of Donepezil formulations. Its presence should be monitored during the drug manufacturing process to ensure the integrity and safety of the final product in medicinal applications. -
Drug Impurity
Ciprofloxacin impurity 5 is a byproduct associated with the production of the antibiotic Ciprofloxacin. It may arise during the synthesis or storage of the drug. This impurity is utilized in quality control studies and method validation to ensure the purity of Ciprofloxacin in pharmaceutical formulations. Its monitoring is essential for assessing drug safety and efficacy in compliance with regulatory standards. -
Drug Impurity
Acebutolol impurity 1 is a specific impurity associated with the β-blocker Acebutolol. This compound is primarily used in the evaluation of drug quality and purity in pharmaceutical research. Its analysis aids in the understanding of the stability and degradation pathways of Acebutolol, which is essential for ensuring the safety and efficacy of therapeutic formulations. -
Drug Impurity
Acetazolamide impurity 3 is a significant impurity associated with the drug Acetazolamide, a carbonic anhydrase inhibitor. This compound is important for assessing the purity of pharmaceutical formulations and can provide insights into the synthesis and quality control of Acetazolamide. Research applications include analytical method development and impurity profiling in drug formulation studies. -
Drug Impurity
Ondansetron impurity 1 is a known impurity associated with the antiemetic agent Ondansetron. It serves as a reference material for quality control and stability studies in pharmaceutical development. This compound is essential for assessing the purity of Ondansetron formulations and ensuring compliance with regulatory standards in drug manufacturing. -
Drug Impurity
Erlotinib impurity 44 is a synthetic byproduct associated with the drug Erlotinib, which primarily targets the epidermal growth factor receptor (EGFR). This impurity is significant for analytical and quality control applications in pharmaceutical research and development, allowing for the evaluation of drug purity and characterization. Its presence and quantification are crucial for maintaining compliance with regulatory standards in drug formulation and safety assessment studies. -
Drug Impurity
Valenklin impurity 1 is a known impurity of the compound Valenklin. This substance serves as an important reference standard for analytical and quality control applications in pharmaceutical research. Its identification and characterization are crucial for ensuring the purity and compliance of Valenklin in drug formulations. -
Drug Impurity
Duloxetine impurity 8 oxalate is a significant impurity related to Duloxetine oxalate. It serves as a key reference standard in quality control and analytical testing of Duloxetine formulations. Research applications include investigating the purity and stability of Duloxetine products, as well as evaluating potential impacts on pharmacological activity. -
Drug Impurity
Prasugrel impurity 4 is a chemical impurity associated with the synthesis of the antiplatelet agent Prasugrel. As a relevant impurity, it is important for pharmaceutical research and quality control in drug development processes. Its identification and quantification are crucial for ensuring the purity and efficacy of Prasugrel formulations in clinical applications. -
Drug Impurity
Ticagrelor impurity 3 is a chemical impurity associated with Ticagrelor, a potent inhibitor of platelet aggregation. This compound is primarily utilized in analytical and quality control studies to assess the purity and stability of Ticagrelor formulations. Its presence can provide insights into the degradation pathways and help ensure the integrity of pharmaceutical products in research and development applications. -
Drug Impurity
Ropinirole impurity 4, also known as Ropinirole N-oxide, is a characterized impurity associated with Ropinirole. As a drug impurity, it serves as an important reference standard for the analysis and quality control of pharmaceutical formulations containing Ropinirole. Its presence can inform the understanding of metabolism and degradation pathways in the synthesis of dopamine agonists, making it relevant for pharmacokinetic studies and regulatory compliance. -
Drug Impurity
Arolol impurity 1 is a chemical impurity associated with the synthesis of Arolol. It is primarily used for analytical and quality control applications in pharmaceutical research and development. This compound aids in understanding the stability and purity of drug formulations, contributing to the optimization of synthesis processes and ensuring compliance with regulatory standards. -
Drug Impurity
Bupropion impurity 8 is a specified chemical impurity associated with the synthesis of Bupropion, a norepinephrine-dopamine reuptake inhibitor. This impurity is essential for quality control and analytical studies in pharmaceutical development. It serves as a reference standard for assessing the purity of Bupropion and can be used in stability testing and method validation. -
Drug Impurity
Famotidine impurity 2 hydrochloride is a designated impurity of Famotidine hydrochloride, primarily utilized in the analysis and characterization of pharmaceutical formulations. This chemical is important for ensuring the quality and safety of Famotidine production, playing a critical role in regulatory compliance and drug development. Researchers can employ Famotidine impurity 2 hydrochloride to study its effects on drug efficacy and purity assessment. -
Drug Intermediate
(R)-Benzyl mandelate is a synthetic intermediate primarily utilized in pharmaceutical synthesis. This compound serves as a versatile building block in the development of various drug molecules, contributing to the advancement of medicinal chemistry. Its unique structural properties facilitate the production of diverse therapeutic agents, making it an essential reagent in chemical research applications. -
Drug Impurity
Carvedilol impurity 7 is a known impurity of Carvedilol, a non-selective beta-adrenergic antagonist. This compound serves as an analytical reference standard for the assessment of drug purity and quality control in pharmaceutical research. Its characterization is crucial for ensuring compliance with regulatory standards in drug development and manufacturing processes. -
Drug Impurity
Rifaximin impurity 4 is a chemical impurity associated with the antibiotic Rifaximin, which primarily targets bacterial RNA synthesis. This compound is relevant for analytical research and quality control in pharmaceutical development, particularly in assessing the purity and stability of Rifaximin formulations. Its presence can significantly impact the efficacy and safety profiles of the final drug. -
Drug Impurity
Candesartan impurity 1 is a chemical impurity associated with the angiotensin II receptor blocker, Candesartan. This impurity may provide insights into the quality control and stability of Candesartan formulations. Its characterization is essential for pharmaceutical research applications, particularly in ensuring the safety and efficacy of Candesartan-based therapies. -
Drug Impurity
Sertraline impurity 1 is a designated impurity associated with the antidepressant sertraline. This compound is significant for quality control and regulatory compliance in pharmaceutical research, particularly during the analysis of drug formulations. It is utilized to assess the purity of sertraline and to ensure the safety and efficacy of its pharmaceutical applications. -
Artemether Impurity
Dihydroartemisinin diketo aldehyde is a known impurity of Artemether, functioning primarily as a structural byproduct. This compound may serve as a useful reference standard in analytical chemistry for assessing the purity of Artemether formulations. Its identification and quantification are essential for ensuring the quality and safety of artemisinin-based therapies in pharmaceutical research. -
Drug Impurity
Apixaban impurity 12 is a known impurity of the anticoagulant Apixaban. This compound serves as a reference standard for analytical methods such as HPLC and LC-MS to ensure the quality and purity of pharmaceutical formulations. Its characterization is essential for regulatory compliance and the development of robust analytical procedures in drug formulation and quality control studies. -
Drug Impurity
Montelukast Impurity 6 is a known impurity of the leukotriene receptor antagonist Montelukast, which primarily targets the CysLT1 receptor. This compound is essential for analytical and quality control studies, as it helps in evaluating the purity of Montelukast formulations. It serves as a reference standard in pharmacokinetic studies and stability assessments related to the therapeutic application of Montelukast in respiratory diseases. -
Drug Intermediate
6-Piperazin-1-yl-isoquinoline hydrochloride is a synthetic compound that serves as an important intermediate in pharmaceutical synthesis. It is utilized in the development of various bioactive molecules and pharmacological agents. Its structural properties facilitate further modification and exploration in drug discovery applications, particularly in the study of neuroactive compounds. -
Drug Impurity
Carvedilol impurity 8 is a known impurity associated with the pharmaceutical compound Carvedilol, primarily utilized in cardiovascular therapies. Its characterization is crucial for pharmaceutical research and quality control, ensuring the purity and safety of Carvedilol formulations. Analytical studies involving this impurity aid in understanding the chemical stability and degradation pathways of the parent drug. -
Drug Impurity
Terbinafine impurity 11 is a chemical impurity associated with Terbinafine, an antifungal agent. This impurity is important for analytical and quality control purposes in pharmaceutical research, helping to assess the purity and safety of Terbinafine formulations. Its characterization is essential for understanding the drug's overall stability and potential impacts on efficacy and patient safety. -
Drug Impurity
Albendazole impurity 8, also known as Methiazole, is a known impurity associated with the drug Albendazole. This compound is utilized primarily in drug development and quality control settings to assess the purity and stability of Albendazole formulations. Its identification and quantification are crucial for ensuring compliance with regulatory standards and understanding potential impacts on therapeutic efficacy. -
Drug Impurity
Famotidine Impurity 16 is a chemical impurity associated with Famotidine, a histamine H2 receptor antagonist. This compound is primarily used in analytical research and quality control for the characterization of pharmaceutical formulations containing Famotidine. Its presence can impact drug efficacy and safety assessment, making it essential for thorough impurity profiling in drug development. -
Drug Impurity
Famotidine impurity 11 is a structural impurity associated with the histamine H2 receptor antagonist famotidine. This compound is essential for evaluating the purity and quality control of pharmaceutical formulations containing famotidine. Its presence can impact the efficacy and safety profiles of drug products, making it crucial for regulatory compliance and analytical research in drug development. -
Drug Impurity
Irbesartan impurity 2, a dimeric impurity of Irbesartan, is produced during the synthetic process of the drug. This compound serves as a reference standard for analytical purposes to evaluate the purity of Irbesartan formulations. It is crucial for quality control and method development in pharmaceutical research and development. -
Drug Impurity
Hydrocortisone impurity 7 is a known impurity of hydrocortisone, primarily studied for its potential impact on drug formulation and stability. This compound is crucial for assessing the purity and quality of hydrocortisone in pharmaceutical applications. Researchers utilize hydrocortisone impurity 7 to better understand the behavior of steroid formulations and ensure compliance with regulatory standards in drug development. -
Drug Impurity
Famotidine impurity 8, also known as Famotidine propionic acid, is a drug impurity associated with Famotidine. This compound serves as an analytical standard for quality control and method validation in pharmaceutical research. Its characterization supports the assessment of the purity and stability of Famotidine formulations, ensuring compliance with regulatory standards in drug development. -
Drug Impurity
Clindamycin phosphate impurity 2 is a known impurity of Clindamycin phosphate, primarily related to its synthesis and formulation. This compound is important for quality control processes in the pharmaceutical industry, ensuring the purity and safety of Clindamycin phosphate formulations. Researchers can utilize this impurity to study its effects and interactions in drug development and stability analyses. -
Drug Impurity
Quetiapine impurity 6 is a chemical impurity associated with the antipsychotic medication Quetiapine. This compound serves as a valuable reference standard for quality control and analytical purposes in pharmaceutical research. Its identification and characterization are essential for assessing the purity and safety of Quetiapine formulations in compliance with regulatory standards. -
Drug Impurity
Rivaroxaban impurity 9 is a chemical impurity associated with Rivaroxaban, an oral anticoagulant that inhibits factor Xa. This impurity is significant for analytical and quality control studies in pharmaceutical research, particularly in the context of drug development and formulation. It provides essential insights into the purity and safety profiles of Rivaroxaban formulations. -
Drug Impurity
Glycopyrronium impurity 1, identified as 5-Nitroisophthalic acid, is an analytical reference standard utilized in quality control and method validation within pharmaceutical research. This compound serves as a significant impurity of Glycopyrronium, which is critical in ensuring the purity and safety of formulations containing this drug. Its presence can be monitored to assess the quality and consistency of glycopyrronium products, aiding in compliance with regulatory standards in drug development. -
Drug Impurity
Itraconazole impurity 14 is a recognized impurity of the antifungal agent itraconazole. This compound is essential for analytical and quality control applications in pharmaceutical research, facilitating the assessment of drug purity and stability. It is particularly relevant in studies involving the synthesis and formulation of itraconazole, ensuring compliance with regulatory standards for drug development. -
Drug Impurity
Moxifloxacin impurity 8 (N-Methyl moxifloxacin hydrochloride) is a known impurity of the antibiotic moxifloxacin. This compound is utilized primarily in analytical studies to assess the purity and quality of moxifloxacin formulations. It serves as an important reference standard in pharmaceutical research and development, ensuring adherence to regulatory guidelines during drug formulation and stability testing. -
Miglitol Impurity
rel-(3R,4S,5S)-1-(2-Hydroxyethyl)-2-(hydroxymethyl)piperidine-3,4,5-triol hydrochloride is identified as an impurity of Miglitol, a pharmaceutical agent used to manage type 2 diabetes. Its structural similarity to Miglitol provides insight into the compound's metabolism and safety profile in drug development. This reagent is valuable for analytical chemistry, allowing for the assessment of purity and identification of potential by-products in the synthesis of Miglitol. -
Drug Impurity
Trazodone impurity 6 is a detected impurity associated with the antidepressant Trazodone. It is essential for evaluating the purity of Trazodone formulations and is useful in pharmaceutical quality control studies. Analysis of this impurity can help ensure compliance with regulatory standards and support research applications in drug development and formulation stability. -
Drug Impurity
Acebutolol impurity 6 is a characterized chemical impurity of the antihypertensive agent Acebutolol. This compound serves as an important reference standard for the identification and quantification of impurities during the drug development process. It is utilized in analytical studies to ensure the quality and compliance of pharmaceutical formulations containing Acebutolol. -
Drug Impurity
Gabapentin acid impurity 3 hydrochloride is a known impurity of Gabapentin acid hydrochloride. This compound serves as a crucial reference standard for quality control and analytical validation in pharmaceutical research. It aids in the assessment of the purity and stability of Gabapentin formulations, contributing to the overall understanding of drug development processes and regulatory compliance. -
Drug Impurity
5-Nitrobenzofuran-2-carboxylic acid is characterized as a drug impurity that may occur in various pharmaceutical formulations. Its presence can impact drug efficacy and stability, making it an important compound to study in drug development and quality control processes. Research involving this compound is crucial for understanding its effects on drug formulation and potential toxicity. -
Drug Impurity
Apremilast impurity 66 is a drug impurity associated with Apremilast, a selective inhibitor of phosphodiesterase 4 (PDE4). This compound serves as an important reference standard for assessing the quality and purity of Apremilast in pharmaceutical formulations. Research applications include stability studies, method validation, and the assessment of synthetic processes in drug development. -
Drug Intermediate
2-Chloroethyl (2-chloroethyl)phosphonate is an organophosphorus compound primarily utilized as a drug intermediate in organic synthesis. Its structure facilitates the formation of phosphonate derivatives, making it a valuable reagent in the development of various bioactive molecules. This compound is essential for researchers engaged in synthetic chemistry and pharmaceutical research aimed at discovering new therapeutic agents. -
Drug Impurity
Ticagrelor impurity 89 is a recognized impurity associated with the antiplatelet agent Ticagrelor, primarily impacting its pharmacological profile. This compound is essential for quality control and analytical studies within pharmaceutical development. It aids in assessing the purity and stability of Ticagrelor formulations, enhancing research into its efficacy and safety in clinical applications. -
Drug Impurity
Clindamycin phosphate impurity 5 is a chemical impurity associated with Clindamycin phosphate. This compound is critical for regulatory compliance and analytical studies related to the quality control of Clindamycin formulations. It may aid in the assessment of drug purity and the identification of potential degradation products in pharmaceutical research. -
Drug Impurity
Roflumilast impurity 1, also known as 3,4-Di(cyclopropylmethoxy) roflumilast, is an impurity associated with the pharmaceutical compound Roflumilast. This substance is relevant for analytical studies and quality control in the synthesis of Roflumilast, serving as an important reference material in drug development and validation processes. Its identification and quantification are critical for ensuring the purity and safety of pharmaceutical formulations. -
Drug Impurity
Levofloxacin Impurity 17 is a known impurity associated with the antibiotic levofloxacin. This compound is utilized in pharmaceutical research to assess the quality and purity of levofloxacin formulations. It is crucial for studying the synthesis, stability, and degradation pathways of levofloxacin, contributing to the development of safe and effective drug products.
